Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Ranging Study Investigating the Efficacy and Safety of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adults With House Dust Mite-associated Allergic Asthma

NCT01930461 is registered in ClinicalTrials.gov with Stallergenes Greer as lead sponsor.

NCT NCT01930461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01930461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Ranging Study Investigating the Efficacy and Safety of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adults With House Dust Mite-associated Allergic Asthma
Lead sponsor
Stallergenes Greer
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2013
Completion date
August 31, 2015
Enrollment
386 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, house dust mite allergy